Scholars@Duke

Screening for asymptomatic carotid artery stenosis: caveat emptor.

Publication ,  Journal Article
Goldstein, LB
Published in: Ann Intern Med
September 2, 2014
Published version (DOI) Link to item

Duke Scholars

Larry Bruce Goldstein
Author Larry Bruce Goldstein Neurology, Stroke and Vascular Neurology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Intern Med

DOI

10.7326/M14-1332

EISSN

1539-3704

Publication Date

September 2, 2014

Volume

161

Issue

5

Start / End Page

370 / 371

Location

United States

Related Subject Headings

  • Stroke
  • Stents
  • Risk Assessment
  • Mass Screening
  • Humans
  • General & Internal Medicine
  • Endarterectomy, Carotid
  • Cost-Benefit Analysis
  • Carotid Stenosis
  • Carotid Arteries
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B. (2014). Screening for asymptomatic carotid artery stenosis: caveat emptor. Ann Intern Med, 161(5), 370–371. https://doi.org/10.7326/M14-1332
Goldstein, Larry B. “Screening for asymptomatic carotid artery stenosis: caveat emptor.” Ann Intern Med 161, no. 5 (September 2, 2014): 370–71. https://doi.org/10.7326/M14-1332.
Goldstein LB. Screening for asymptomatic carotid artery stenosis: caveat emptor. Ann Intern Med. 2014 Sep 2;161(5):370–1.
Goldstein, Larry B. “Screening for asymptomatic carotid artery stenosis: caveat emptor.” Ann Intern Med, vol. 161, no. 5, Sept. 2014, pp. 370–71. Pubmed, doi:10.7326/M14-1332.
Goldstein LB. Screening for asymptomatic carotid artery stenosis: caveat emptor. Ann Intern Med. 2014 Sep 2;161(5):370–371.

Published In

Ann Intern Med

DOI

10.7326/M14-1332

EISSN

1539-3704

Publication Date

September 2, 2014

Volume

161

Issue

5

Start / End Page

370 / 371

Location

United States

Related Subject Headings

  • Stroke
  • Stents
  • Risk Assessment
  • Mass Screening
  • Humans
  • General & Internal Medicine
  • Endarterectomy, Carotid
  • Cost-Benefit Analysis
  • Carotid Stenosis
  • Carotid Arteries